UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹99 Cr | ₹92 Cr | ₹108 Cr | ₹144 Cr | ₹49 Cr |
What is the latest Total Non-Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹108 Cr |
| Mar2022 | ₹144 Cr |
| Mar2021 | ₹49 Cr |
How is Total Non-Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | 6.99 | |
| Mar2024 | ₹92 Cr | -14.59 | |
| Mar2023 | ₹108 Cr | -24.92 | |
| Mar2022 | ₹144 Cr | 192.65 | |
| Mar2021 | ₹49 Cr | - | |
Compare Total Non-Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹2,987.4 Cr | -1% | -0.8% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -1% |
-0.8% |
-40.2% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses